3//SEC Filing
Dexcel Pharma Technologies Ltd. 3
Accession 0001144204-19-007576
CIK 0001638381other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:52 AM ET
Size
5.6 KB
Accession
0001144204-19-007576
Insider Transaction Report
Form 3
Dexcel Pharma Technologies Ltd.
10% Owner
Holdings
- 5,150,848
Ordinary Shares
Oren Dan
10% Owner
Holdings
- 5,150,848
Ordinary Shares
Footnotes (1)
- [F1]Dexcel Pharma Technologies Ltd. ("DPT") and DPT's President and Chief Executive Officer, Dan Oren, are filing this Form 3 because they may be deemed to have beneficial ownership over 5,150,848 ordinary shares (the "Common Shares") of Intec Pharma Ltd. (the "Issuer"). The Common Shares are directly owned by DPT. Mr. Oren is ultimately the sole shareholder of DPT.
Documents
Issuer
Intec Pharma Ltd.
CIK 0001638381
Entity typeother
IncorporatedIsrael
Related Parties
1- filerCIK 0001720007
Filing Metadata
- Form type
- 3
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 8:52 AM ET
- Size
- 5.6 KB